Process for producing acesulfame potassium

In one embodiment, the invention relates to processes for producing acesulfame potassium. In one embodiment, the process comprises the step of reacting a first reaction mixture to form an amidosulfamic acid salt such as a trialkyl ammonium amidosulfamic acid salt. The first reaction mixture comprises sulfamic acid, an amine, and smaller amounts, if any, acetic acid, e.g., less than 1 wt % (10000 wppm). In terms of ranges, the first reaction mixture may comprise from 1 wppm to 1 wt % acetic acid. The process further comprises the step of reacting the amidosulfamic acid salt with diketene to form an acetoacetamide salt. In preferred embodiments, the amidosulfamic acid salt formation reaction is conducted at pH levels from 5.5 to 7.0. The process further comprises the step of deriving the acesulfame-K from the acetoacetamide salt.

Skip to: Description  ·  Claims  ·  References Cited  · Patent History  ·  Patent History
Description
CROSS REFERENCE TO RELATED APPLICATIONS

This application is a non-provisional of and claims priority to U.S. Provisional Application No. 61/657,231, which was filed on Jun. 8, 2012. reissue of U.S. Pat. No. 9,024,016, which issued from U.S. application Ser. No. 13/901,735, filed on May 24, 2013. The entirety entireties of this patent and application is are incorporated by reference herein.

FIELD OF INVENTION

The present invention relates generally to the production of acesulfame potassium. More specifically, the present invention relates to the production of acesulfame potassium and/or acesulfame potassium intermediates having low yellowing indices.

BACKGROUND OF THE INVENTION

Acesulfame potassium (“Acesulfame-K”) has an intense, sweet taste and has been used in many food-related applications. In conventional acesulfame-K production processes, sulfamic acid and an amine, e.g., triethyleamine, are reacted to form an amidosulfamic acid salt. As one example, the amidosulfamic acid salt may be a trialkyl ammonium amidosulfamic acid salt. The amidosulfamic acid salt may then be reacted with diketene to form an acetoacetamide salt. The acetoacetamide salt may be cyclized, hydrolyzed, and neutralized to form the Acesulfame-K. U.S. Pat. No. 5,744,010 discloses an exemplary acesulfame-K production process.

Typically, to initiate and efficiently maintain the reaction under production-scale conditions, acetic acid is added to the sulfamic acid and amine. The acetic acid may form a corresponding ammonium acetate salt, which may promote the acetoacetylation reaction that forms the acetoacetamide salt. The sulfamic acid (and in some cases acetic acid) create acidic reaction conditions, which may drive down pH of the reaction mixtures, e.g., to a pH level less than 5.5. In some cases, e.g., to create a more neutral environment, amine may be added to the reaction in amounts greater than the stoichiometric amounts, e.g., the reaction is conducted in an excess of amine. This use of excess amine and the accompanying increase in pH, however, may cause coloration problems in the resultant acetoacetamide salt.

Even in view of the conventional processes, the need exists for an improved acesulfame-K production process that utilizes smaller amounts of reactants, e.g., acetic acid and/or amine, and produces a high quality acesulfame-K product at improved yield rates.

All of the references discussed above are hereby incorporated by reference.

SUMMARY OF THE INVENTION

The present invention relates to processes for producing acesulfame potassium. In one embodiment, the process comprises the step of reacting a first reaction mixture to form an amidosulfamic acid salt such as a trialkyl ammonium amidosulfamic acid salt. The first reaction mixture comprises sulfamic acid, an amine, e.g., triethylamine, and smaller amounts, if any, acetic acid, e.g., less than 1 wt % (10000 wppm). In terms of ranges, the first reaction mixture may comprise from 1 wppm to 1 wt % acetic acid. The process further comprises the step of reacting the amidosulfamic acid salt with diketene to form an acetoacetamide salt. In preferred embodiments, the amidosulfamic acid salt formation reaction is conducted at pH levels from 5.5 to 7.0. The process further comprises the step of deriving the acesulfame-K from the acetoacetamide salt, which may comprise the steps of reacting the acetoacetamide salt with a cyclizing agent to form a cyclic sulfur trioxide adduct and deriving the acesulfame potassium composition from the cyclic sulfur trioxide adduct. The deriving may comprise hydrolyzing the cyclic sulfur trioxide adduct to form acesulfame-H and neutralizing the acesulfame-H with potassium hydroxide to form the potassium acesulfame. In one embodiment, a molar ratio of acetic acid to sulfamic acid in the first reaction mixture is less than 0.095:1. A molar ratio of amine to sulfamic acid in the first reaction mixture may be less than 1.06:1. The reaction may be conducted at an amine excess of less than 6 mol %. In one embodiment, the amidosulfamic acid salt may have a yellowing index less than 5 and/or the acetoacetamide salt may have a yellowing index less than 45. The acesulfame potassium may have a yellowing index less than 5. In one embodiment, the process does not comprise an acetic acid removal step. The reaction of the amidosulfamic acid salt with diketene may comprise contacting the amidosulfamic acid salt and diketene to form a second reaction mixture and reacting the second reaction mixture to form the acetoacetamide salt. Also disclosed are acesulfame potassium, amidosumfamic acid salt, and acetoacetamide salt produced by the process. In some embodiments, the invention relates to a process for producing an amidosulfamic acid salt comprising the step of reacting sulfamic acid, an amine and less than 10000 wppm acetic acid to form the amidosulfamic acid salt. The reacting may be conducted at a pH ranging from 5.5 to 7.0. In some embodiment, the invention relates to a process for producing an acetoacetamide salt comprising the steps of reacting sulfamic acid, an amine and from 1 wppm to 10000 wppm acetic acid to form an amidosulfamic acid salt reacting the amidosulfamic acid salt with diketene to form the acetoacetamide salt. In one embodiment, the amidosulfamic acid salt has a yellowing index less than 5 and/or the acetoacetamide salt has a yellowing index less than 45.

BRIEF DESCRIPTION OF THE DRAWINGS

The invention is described in detail below with reference to the appended drawings.

FIG. 1 is a process flow sheet of an acesulfame-K production process in accordance with one embodiment of the present invention.

 DETAILED DESCRIPTION OF THE INVENTION

Introduction

Conventional processes for producing acesulfame-K react sulfamic acid, an amine and acetic acid to form an amidosulfamic acid salt. Typically, under production-scale conditions, the acetic acid is added to the sulfamic acid and amine to initiate and efficiently maintain the reaction. As such, the acetic acid is typically present in higher amounts, e.g., greater than 1 wt %, based on the total weight of the reactants in the reaction mixture (not including solvent). If solvent is included in the weight percentage calculation, the acetic acid typically may be present in an amount greater than 0.15 wt %. The reaction is usually conducted in excess of amine, which drives up the pH at which the reaction is conducted. The amidosulfamic acid salt is then reacted with an acetoacetylating agent, e.g, diketene, to form an acetoacetamide salt. The use of excess amine and the accompanying increase in pH has been found to cause coloration problems in the resultant acetoacetamide salt.

It has now been discovered that, in contrast to conventional processes, the use of lower amounts (if any) of acetic acid in the amidosulfamic acid salt formation reaction can effectively initiate and maintain the reaction. The reaction then may be conducted using smaller amounts of amine, e.g., lesser excesses. In one embodiment, the amidosulfamic acid salt formation reaction may be conducted at a pH levels ranging from 5.5 to 7.0. As a result, both the yield and the color properties of the resultant acetoacetamide salt may be improved. Also, because the amount of additional acetic acid added to the reaction may be reduced or eliminated, smaller amounts of raw materials can be used to form the same amount of product, which result in additional process efficiencies. In addition, the process components that are required to provide acetic acid and/or amine, e.g., tanks, lines, pumps, etc., may advantageously be reduced or eliminated, resulting in lower capital costs.

Acesulfame-K Formation

The present invention relates to processes for producing acesulfame-K. In one embodiment, the process comprises the step of reacting a reaction mixture, e.g., a first reaction mixture, to form an amidosulfamic acid salt, e.g., a trialkyl ammonium amidosulfamic acid salt. The first reaction mixture comprises sulfamic acid, amine, and lower amounts (if any) of acetic acid. In a preferred embodiment, the first reaction mixture comprises acetic acid in amounts less than 1 wt %, e.g., less than 900 wppm, less than 800 wppm, less than 500 wppm, or less than 100 wppm, based on the total weight of the reactants in the reaction mixture (not including solvent). In terms of ranges, the first reaction mixture may comprise from 1 wppm to 1 wt % acetic acid, e.g., from 1 wppm to 900 wppm, from 1 wppm to 800 wppm, from 1 wppm to 500 wppm, from 10 wppm to 1 wt %, from 10 wppm to 900 wppm, from 10 wppm to 800 from, from 10 wppm to 500 wppm, from 100 wppm to 1 wt %, wppm, from 100 wppm to 900 wppm, from 100 wppm to 800 wppm, or from 100 wppm to 500 wppm. In one embodiment, the first reaction mixture is substantially free of acetic acid, e.g., acetic acid is beneficially eliminated as a reactant. Typically, the acetic acid is added to the sulfamic acid and the amine to initiate and efficiently maintain the reaction under production-scale conditions. In some laboratory conditions, e.g., small-scale batch operations, the rate at which the reaction is initiated is not affected by production constraints. As such, in these small-scale batch operations, it may be unnecessary to add acetic acid. Under conventional production-scale processes, however, higher amounts of acetic acid are typically utilized in the reaction mixture. When solvent is included in the weight percentage calculation, the first reaction mixture may comprise acetic acid in amounts less than 0.175 wt %, e.g., less than 0.15 wt %, less than 0.10 wt %, less than 0.08 wt %, or less than 0.05 wt %. In terms of ranges, the first reaction mixture may comprise from 1 wppm to 150 wppm acetic acid, e.g., from 1 wppm to 100 wppm, from 1 wppm to 80 wppm, or from 1 wppm to 50 wppm.

The lower amounts of acetic acid employed in the present invention advantageously reduce raw material cost. Also, in conventional processes, because higher amounts of acetic acid are used, acetic acid removal steps are often required to provide a purified acesulfame-K intermediate, e.g., the amidosulfamic acid salt and/or the acetoacetamide salt. The lower levels of acetic acid employed in the present invention result in the reduction or elimination of the need for a separate acetic acid removal step during the formation of the acesulfame-K intermediates.

As noted above, the amount of acetic acid employed in conventional amidosulfamic acid salt formation reaction is significantly higher than that used in the reaction of the present invention. In some embodiments of the present invention, the inventive use of lower amounts of acetic acid requires less amine in the first reaction mixture. Beneficially, the use of lower amounts of amine advantageously reduces raw material cost. In one embodiment, the pH at which the amidosulfamic acid salt formation reaction is conducted may range from 5.5 to 7.0, e.g., from 5.9 to 6.8 or from 6.1 to 6.4. In terms of lower limits, the reaction may be conducted at a pH at least 5.5, e.g., at least 5.7, at least 5.9, or at least 6.1. In terms of upper limits, the reaction may be conducted at a pH less than 7.0, e.g., less than 6.8, or less than 6.4. By conducting the reaction in accordance with the inventive reaction parameters yield, surprisingly and unexpectedly, is improved.

Also, by employing the inventive reaction parameters, the amidosulfamic acid salt that is formed, surprisingly, has improved color properties, e.g., a yellowing index less than 5, e.g., less than 2, less than 1 or less than 0.5, as formed, as determined by ASTM E313. In addition, the acetoacetamide salt that may be subsequently formed from the amidosulfamic acid salt, unexpectedly, may also demonstrate improved color properties, e.g., a yellowing index less than 45, e.g., less than 35, less than 25, or less than 10, as formed. Some conventional processes that operate at pH levels higher than those of the present invention may yield: 1) an amidosulfamic acid salt having a yellowing index greater than 5; and/or 2) an acetoacetamide salt having a yellowing index greater than 45.

Because the inventive amidosulfamic acid salts and acetoacetamide salts have improved color properties, the acesulfame-K, as formed therefrom, may have improved color properties, as compared to conventional acesulfame-K products. In a preferred embodiment, the acesulfame-K, as formed, has a yellowing index less than 5, e.g., less than 3, less than 2, less than 1, or less than 0.5.

In one embodiment, the reaction of the first reaction mixture is conducted at higher temperatures. For example the reaction may be conducted at temperatures greater than 0° C., e.g., greater than 10° C., or greater than 25° C. In one embodiment, the reaction is conducted at temperatures above room temperature. In small-scale batch processes, where the cooling of the reactants and maintenance of lower reaction temperatures is economically feasible, a similar reaction may not be conducted at higher temperatures and instead may be conducted at much lower temperatures, e.g., less than 25° C. or less than 10° C.

In one embodiment, the inventive process is not a small-scale batch process or a laboratory-scale process. For example, the inventive process may yield at least 50 grams of acesulfame-K per batch, e.g., at least 100 grams of acesulfame-K per batch, at least 500 grams of acesulfame-K per batch, at least 1 kilogram of acesulfame-K per batch, or at least 10 kilograms of acesulfame-K per batch. In terms of rates, the inventive process may yield at least 50 grams of acesulfame-K per hour, e.g., at least 100 grams of acesulfame-K per hour, at least 500 grams of acesulfame-K per hour, at least 1 kilogram of acesulfame-K per hour, or at least 10 kilograms of acesulfame-K per hour.

The process further comprises the step of reacting the amidosulfamic acid salt with diketene to form an acetoacetamide salt. In one embodiment, the acetoacetamide salt is conducted in the same reactor as is the amidosulfamic acid salt formation reaction. In a preferred embodiment, the two reactions are conducted in separate reactors. As one example, the reaction product of the amidosulfamic acid salt formation reaction is fed to the acetoacetamide salt formation reactor, wherein the amidosulfamic acid salt is reacted to form the acetoacetamide salt.

In embodiments wherein the two reactions are conducted in the same reactor, the reactions may be conducted at the same pH level.

In embodiments wherein the two reaction are conducted in separate reactors, the acetoacetamide salt formation reaction is conducted at a pH ranging from 5.5 to 7.0, e.g., from 5.9 to 6.8 or from 6.1 to 6.4. In terms of lower limits, the reaction may be conducted at a pH at least 5.5, e.g., at least 5.7, at least 5.9, or at least 6.1. In terms of upper limits, the reaction may be conducted at a pH less than 7.0, e.g., less than 6.8, or less than 6.4. In a preferred embodiment, the pH at which the amidosulfamic acid salt formation reaction is conducted is similar to or the same as that of the acetoacetamide salt formation reaction. In one embodiment, the pH levels of the two reactions may differ from one another.

The process preferably further comprises the step of deriving the acesulfame-K from the acetoacetamide salt. In a preferred embodiment, this deriving involves the following steps: reacting the acetoacetamide salt with a cyclizing agent to form a cyclic sulfur trioxide adduct; hydrolyzing the cyclic sulfur trioxide adduct to form acesulfame-H; and neutralizing the acesulfame-H with potassium hydroxide to form the acesulfame-K.

As discussed, in a first reaction step, sulfamic acid and the amine are reacted to form the amidosulfamic acid salt. An exemplary reaction scheme that employs triethylamine as the amine and yields triethyl ammonium amidosulfamic acid salt is shown below.
H2N—SO3H+N(C2H5)3→H2N—SO3−·HN+(C2H5)3

Acetic acid is also present in the first reaction mixture. Acetic acid may react with the amine, e.g., triethylamine, to form a triethylammonium acetate. An exemplary reaction scheme that employs triethylamine as the amine is shown below.
H3C—COOH+N(C2H5)3→H3C—COO−·HN+(C2H5)3

In conventional processes, acetic acid is added to these reactants in higher amounts, e.g., in amounts greater than 1 wt % acetic acid. The addition of acetic acid affects the pH at which the reaction is conducted. The addition of amine to a mixture may increase the pH of the mixture to which the amines are added. Thus, in addition to acetic acid content, the presence of amine in the reaction mixture may also affect the pH at which the reaction is conducted. As such, the amine not only serves as a reactant, but may also adjust the pH of the reaction mixture. In one embodiment, the amine is present in amounts in excess of the stoichiometric amount. In one embodiment, the amidosulfamic acid salt formation reaction is conducted at an amine excess of less than 6 mol %, e.g., less than 5 mol % or less than 3 mol %. In the process of the present invention, however, less acetic acid is used in the first reaction mixture. Accordingly, less amine(s) are required to achieve the desired pH level, as compared to conventional reactions that employ higher amounts of acetic acid.

In one embodiment, the first reaction mixture comprises from 35 wt % to 75 wt % amine(s), e.g., from 45 wt % to 65 wt % or from 50 wt % to 60 wt %, based on the total weight of the first reaction mixture, excluding solvent. In terms of upper limits, the first reaction mixture may comprise less than 75 wt % amine(s), e.g., less than 65 wt % or less than 60 wt %. In terms of lower limits, the first reaction mixture may comprise at least 35 wt % amine(s), e.g., at least 45 wt % or at least 50 wt %. The first reaction mixture may also comprise a solvent. In one embodiment, the first reaction mixture comprises from 45 wt % to 85 wt % solvent, e.g., from 55 wt % to 75 wt % or from 60 wt % to 70 wt %. Exemplary solvents are discussed herein.

In one embodiment, the first reaction mixture has a molar ratio of acetic acid to sulfamic acid that is less than 0.095:1 e.g., less than 0.06:1, less than 0.01:1 or less than 0.001:1. In terms of ranges, the first reaction mixture may have a molar ratio of acetic acid to sulfamic acid in the range of 0.0001:1 to 0.095:1, e.g., from 0.001:1 to 0.06:1.

In one embodiment, a molar ratio of amine(s) to sulfamic acid in the first reaction mixture is greater than 1:1, e.g., greater than 1.02:1 or greater than 1.05:1.

The amine that is employed in this reaction may vary widely. Preferably, the amine comprises triethylamine. In one embodiment, the amine may be selected from the group consisting of trimethylamine, diethylpropylamine, tri-n-propylamine, triisopropylamine, ethyldiisopropylamine, tri-n-butylamine, triisobutylamine, tricyclohexylamine, ethyldicyclohexylamine, N,N-dimethylaniline, N,N-diethylaniline, benzyldimethylamine, pyridine, substituted pyridines such as picoline, lutidine, cholidine or methylethylpyridine, N-methylpiperidine, N-ethylpiperidine, N-methylmorpholine, N,N-dimethylpiperazine, 1,5-diazabicyclo[4.3.0]-non-5-en, 1,8-diazabicyclo-[5.4.0]-undec-7-en, 1,4-diazabicyclooctane, tetramethylhexamethylendiamine, tetramethylethylendiamine, tetramethylpropylendiamine, tetramethylbutylendiamine, 1,2-dimorpholylethan, pentamethyldiethyltriamine, pentaethyldiethylentriamine, pentamethyldipropylentriamine, tetramethyldiaminomethane, tetrapropyldiaminomethane, hexamethyltriethylentetramine, hexamethyltripropylenetetramine, diisobutylentriamine, triisopropylentriamine, and mixtures thereof.

Returning to the acetoacetamide salt formation reaction, amidosulfamic acid salt and an acetoacetylating agent are reacted to form the acetoacetamide salt. Preferably, the acetoacetylating agent is diketene, although other acetoacetylating agents may be employed, either with or without diketene.

In one embodiment, the resultant acetoacetamide salt may correspond to the following formula.

where M+ is an appropriate metal ion,

Preferably, M+ is Li+ or N+R1R2R3R4. R1, R2, R3 and R4, independently of one another, may be organic radicals or hydrogen, preferably H or C1-C8 alkyl, C6-C10 cycloalkyl, aryl and/or aralkyl.

In one embodiment, the total number of carbon atoms in the ammonium ion in the ammonium salts is not more than about 20, in particular not more than about 10.

An exemplary reaction scheme that employs a trialkyl ammonium amidosulfamic acid salt and diketene as reactants and yields an acetoacetamide triethylammonium salt is shown below.

In one embodiment, the reaction is conducted in the presence of a catalyst. The catalyst may vary widely. In some embodiments, the catalyst comprises one or more amines and/or phosphines. Preferably, the catalyst is triethylamine. In addition to triethylamine, other exemplary amine catalysts include the amines listed above with respect the amidosulfamic acid salt formation reaction. Exemplary phosphines include methyldiphenylphosphine, triphenylphosphine, tributylphosphine. In one embodiment, the acetoacetamide salt formation reaction takes place without a catalyst.

In one embodiment wherein the amidosulfamic acid salt formation reaction and the acetoacetamide salt formation reaction are conducted in separate reactors, a second reaction mixture comprises the amidosulfamic acid salt, the diketene, and the catalyst, e.g., triethylamine. Preferably, catalyst from the first reaction is carried through to the reaction mixture of the second reaction. The second reaction mixture is then subjected to conditions effective to form the acetoacetamide salt. Preferably, the second reaction mixture comprises essentially no acetic acid.

In one embodiment, the composition of the second reaction mixture may be similar to that of the first reaction mixture, discussed above. In one embodiment, when the weight of the solvent is taken into consideration in the weight percentage calculation, the second reaction mixture comprises less than 0.157 wt % acetic acid, e.g., less than 0.15 wt %, less than 0.10 wt %, less than 0.8 wt %, or less than 0.5 wt %, based on. In some embodiments, the second reaction mixture may further comprise from 3 wt % to 45 wt % amidosulfamic acid salt, e.g., from 13 wt % to 35 wt % or from 18 wt % to 30 wt %; from 1 wt % to 30 wt % diketene, e.g., from 1 wt % to 20 wt % or from 5 wt % to 15 wt %; and/or from 45 wt % to 85 wt % solvent, e.g., from 55 wt % to 75 wt % or from 60 wt % to 70 wt %. In a preferred embodiment, the reaction product of the amidosulfamic acid salt formation reaction provides the amidosulfamic acid salt component of the second reaction mixture. In addition to the above-mentioned components, the second reaction mixture may further comprise reaction by-products from the first reaction, e.g., (residual) ammonium acetate salt.

In one embodiment, the amount of acetoacetylating agent, e.g., diketene, should be at least equimolar to the reactant amidosulfamic acid salt. In one embodiment, the process may utilize a diketene excess less than 30 mol %, e.g., less than 10 mol %. Greater excesses are also contemplated.

The first and/or second reaction may employ an organic solvent. Suitable inert organic solvents are virtually all organic solvents which do not react in an undesired manner with the starting materials, final products and/or the catalysts in the reaction. The solvents preferably have the ability to dissolve, at least partially, amidosulfamic acid salts. Exemplary organic solvents include halogenated aliphatic hydrocarbons, preferably those having up to 4 carbon atoms such as, for example, methylene chloride, chloroform, 1,2-dichlorethane, trichloroethylene, tetrachloroethylene, trichlorofluoroethylene; aliphatic ketones, preferably those having 3 to 6 carbon atoms such as, for example, acetone, methyl ethyl ketone; aliphatic ethers, preferably cyclic aliphatic ethers having 4 or 5 carbon atoms such as, for example, tetrahydrofuran, dioxane; lower aliphatic carboxylic acids, preferably those having 2 to 6 carbon atoms such as, for example, acetic acid, propionic acid; aliphatic nitriles, preferably acetonitrile; N-alkyl-substituted amides of carbonic acid and lower aliphatic carboxylic acids, preferably amides having up to 5 carbon atoms such as, for example, tetramethylurea, dimethylformamide, dimethylacetamide, N-methylpyrrolidone; aliphatic sulfoxides, preferably dimethyl sulfoxide, and aliphatic sulfones, preferably sulfolane.

Particularly preferred solvents include methylene chloride, 1,2-dichloroethane, acetone, glacial acetic acid and dimethylformamide, with methylene dichloride being particularly preferred. The solvents may be used either alone or in a mixture.

In one embodiment, the reaction is conducted a temperature ranging from −30° C. to 50° C., e.g., from 0° C. to 25° C. The reaction pressure may vary widely. In preferred embodiments, the reaction is carried out at atmospheric pressure. The reaction time may vary widely, preferably ranging from 0.5 hours to 12 hours, e.g., from 1 hour to 10 hours. In embodiment, the reaction is carried out by introducing the amidosulfamic acid salt and metering in the diketene. In one embodiment, the reaction is carried out by introducing diketene and metering in the amidosulfamic acid salt. The reaction may be carried out by introducing the diketene and amidosulfamic acid and metering in the catalyst.

Once formed, the reaction product is preferably subjected to one or more purification steps. For example the solvent may be separated from the reaction product, e.g., via distillation, and the residue (mainly acetoacetamide-N-sulfonate) may be recrystallized from a suitable solvent such as, for example, acetone, methyl acetate or ethanol.

Cyclization, Hydrolyzation and Neutralization

The acetacetamide salt, in preferred embodiments, is reacted with a cyclizing agent to form a cyclic sulfur trioxide adduct. In one embodiment, the cyclization is achieved by using at least an equimolar amount of the cyclizing agent, e.g., sulfur trioxide, which may be dissolved in an inert inorganic or organic solvent. The sulfur trioxide is generally used in a molar excess, e.g., up to a 20 fold excess, or up to a 10 fold excess, based on the acetoacetamide salt. An exemplary cyclization reaction is shown below.

The sulfur trioxide may be added to the reaction mixture either in the solid or the liquid form or by condensing in sulfur trioxide vapor. Preferably, a solution of sulfur trioxide in 1) concentrated sulfuric acid, 2) liquid sulfur dioxide, or 3) an inert organic solvent is used. In one embodiment, the reaction is carried out without a solvent. Suitable inert inorganic or organic solvents are those liquids which do not react in an undesired manner with sulfur trioxide or the starting materials or final products of the reaction. Preferred inorganic solvents include, but are not limited to liquid sulfur dioxide. Preferred organic solvents include, but are not limited to halogenated aliphatic hydrocarbons, preferably having up to 4 carbon atoms, such as, for example, methylene chloride (dichloro methane), chloroform, 1,2-dichloroethane, trichloroethylene, tetrachloroethylene, trichlorofluoroethylene; esters of carbonic acid with lower aliphatic alcohols, preferably with methanol or ethanol; nitroalkanes, preferably having up to 4 carbon atoms, in particular nitromethane; alkyl-substituted pyridines, preferably collidine; and aliphatic sulfones, preferably sulfolane. The processes may employ these solvents alone or in mixtures thereof.

In a preferred embodiment, the same solvent is used in both the acetoacetamide salt formation reaction and the cyclization reaction. As one benefit, the solution obtained in the acetoacetamide salt formation reaction, without isolation of the acetoacetamide salt formation reaction, may be used immediately in the cyclization.

In one embodiment, the reaction temperature for the cyclization reaction ranges from −70° C. to 175° C., e.g., from −40 ° C. to 10° C. The pressure at which the reaction is conducted may vary widely. In one embodiment, the reaction is conducted at a pressure ranging from 0.01 MPa to 10 MPa, e.g., from 0.1 MPa to 5 MPa. Preferably, the reaction is conducted at atmospheric pressure.

The acetoacetamide salt may be introduced to the reactor and the sulfur trioxide is metered into the reactor. In preferred embodiments, both reactants are simultaneously fed into the reactor. In one embodiment, sulfur trioxide initially introduced into the reactor and the acetoacetamide salt is added. Preferably, at least part of the sulfur trioxide is introduced into the reactor and, either continuously or in portions, acetoacetamide salt and (additional) sulfur trioxide are then metered in.

The cyclic sulfur trioxide adduct may be hydrolyzed and neutralized via conventional means. In cases where methylene chloride is used as the reaction medium, water or ice may be added, e.g., in a molar excess, based on the sulfur trioxide, to the cyclic sulfur trioxide adduct/sulfur trioxide solution. An exemplary hydrolysis reaction scheme is shown below.

The addition of the water leads to a phase separation. The sweetener acid, acesulfame-H (6-methyl-3,4-dihydro-1,2,3-oxathiazin-4one 2,2-dioxide), which is formed via the hydrolysis, is present in the organic phase.

After the addition of water, the reaction solvent may be removed by distillation, and the acesulfame-H that remains in the organic phase may be extracted with a more suitable solvent. Suitable solvents are those which are sufficiently stable towards sulfuric acid and which have a satisfactory dissolving capacity. Other suitable solvents include esters of carbonic acid such as, for example dimethyl carbonate, diethyl carbonate and ethylene carbonate, or esters of organic monocarboxylic acids such as, for example, isopropyl formate and isobutyl formate, ethyl acetate, isopropyl acetate, butyl acetate, isobutyl acetate and neopentyl acetate, or esters of dicarboxylic acids or amides which are immiscible with water, such as, for example, tetrabutylurea, are suitable. Isopropyl acetate and isobutyl acetate are particularly preferred.

The combined organic phases are dried with, for example, Na2SO4, and are evaporated. Any sulfuric acid which has been carried over in the extraction can be removed by appropriate addition of aqueous alkali to the organic phase. For this purpose, dilute aqueous alkali may be added to the organic phase until the pH reached in the aqueous phase corresponds to that of pure 6-methyl-3,4-dihydro1,2,3-oxathiazin-4-one 2,2-dioxide at the same concentration in the same two-phase system of extracting agent and water.

The neutralization of the acesulfame-H yields a non-toxic salt of acesulfame-H, e.g., acesulfame-K. In one embodiment, the neutralization is carried out by reacting the acesulfame-H with an appropriate base, e.g., potassium hydroxide. Other suitable bases include, for example, KOH, KHCO3, K2 CO3, potassium alcoholates. An exemplary reaction scheme using potassium hydroxide as a neutralizing agent is shown below.

In one embodiment, the acesulfame-H may be neutralized and extracted directly from the purified organic extraction phase using an aqueous potassium base. The acesulfame-K then precipitates out, where appropriate after evaporation of the solution, in the crystalline form, and it can also be recrystallized for purification.

FIG. 1 shows exemplary acesulfame-K process 100, which is in accordance with the present invention. Process 100 comprises amidosufamic acid salt formation reactor 102 and acetoacetamide salt formation reactor 104. Although FIG. 1 shows separate reactors for the two intermediate formation reactions, other configurations, e.g., a one reactor process, are within the contemplation of the present invention. Sulfamic acid is fed to amidosufamic acid salt formation reactor 102 via sulfamic acid feed 106. Amine(s), preferably triethylamine, are fed to amidosufamic acid salt formation reactor 102 via amine feed line 108. In addition to sulfamic acid and amine(s), acetic acid is also fed to amidosufamic acid salt formation reactor 102 (via line 110 ). The resultant reaction mixture in amidosufamic acid salt formation reactor 102 is as discussed above. In amidosufamic acid salt formation reactor 102, the sulfamic acid and the amine (in the presence of the acetic acid) are reacted to yield a crude amidosufamic acid salt composition, which exits reactor 102 via line 112. By controlling the feed rate of the acetic acid and/or the amide(s), the reaction in amidosufamic acid salt formation reactor 102 is maintained at the inventive pH levels. Although not shown, a reaction solvent, e.g., methylene dichloride may also be present in amidosufamic acid salt formation reactor 102.

The crude amidosufamic acid salt composition in line 112 is directed to acetoacetamide salt formation reactor 104. Diketene is fed to acetoacetamide salt formation reactor 104 via line 114. The resultant reaction mixture in acetoacetamide salt formation reactor 104 is as discussed above. In acetoacetamide salt formation reactor 104, the amidosufamic acid salt and the diketene are reacted to yield a crude acetoacetomide salt composition, which exits reactor 104 via line 118. By controlling the feed rate of the amide(s), the reaction in acetoacetamide salt formation reactor 104 is maintained at the inventive pH levels. Although not shown, methylene dichloride may also be present in acetoacetamide salt formation reactor 104.

The crude acetoacetomide salt composition is directed to cyclization reactor 120. Sulfur trioxide is also fed to cyclization reactor 120 (via line 122 ). In cyclization reactor 120, the acetoacetamide salt in line 118 is cyclized and a cyclic sulfur trioxide adduct stream, which exits via line 124.

Line 124, which contains the cyclic sulfur trioxide adduct, is directed to hydrolysis reactor 126. Water is fed to hydrolysis reactor 126 via water feed 128. In hydrolysis reactor 126, the cyclic sulfur trioxide adduct is hydrolyzed to yield a crude acesulfame-H stream, which exits hydrolysis reactor 126 via line 130 and is directed to phase separation unit 132. Phase separation unit 132 separates the contents of line 130 into an organic phase 134 and an aqueous phase 136. Organic phase 134 comprises a major amount of the acesulfame-H in line 130 as well as solvent, e.g., methylene chloride. Aqueous phase 136 exits via line 137 and comprises triethylammonium sulfate, and optionally sulfuric acid and minor amounts of acesulfame-H. This phase may be further purified to separate and/or recover the acesulfame-H and/or the triethylammonium sulfate. The recovered acesulfame-H may be combined with the acesulfame from the organic phase (not shown).

The organic phase exits phase separation unit 132 and is directed to extraction column 138 (via line 140 ). Water is fed to extraction column 138 via water feed 142. The water extracts residual sulfates from the contents of line 140 and a purified acesulfame-H stream exits extraction column 138 via line 144. The extracted sulfates exit extraction column 138 via line 145.

Line 144 is directed to neutralization unit 146. Potassium hydroxide is also fed to neutralization unit 146 (via line 148 ). The potassium hydroxide neutralizes the acesulfame-H to yield a crude acesulfame-K product, which exits neutralization unit 146 via line 150. The crude acesulfame-K product stream comprises acesulfame-K, methylene dichloride, water, and potassium hydroxide. The crude acesulfame-K product stream in line 150 may be directed to further processing to recover purified acesulfame-K, which is shown exiting via stream 152. In addition to the purified acesulfame-K, methylene dichloride and potassium hydroxide may be separated from the crude acesulfame-K product stream, as shown by stream 154. The contents of stream 154 may be recovered and/or recycled to the process.

While the invention has been described in detail, modifications within the spirit and scope of the invention will be readily apparent to those of skill in the art. In view of the foregoing discussion, relevant knowledge in the art and references discussed above in connection with the Background and Detailed Description, the disclosures of which are all incorporated herein by reference. In addition, it should be understood that aspects of the invention and portions of various embodiments and various features recited below and/or in the appended claims may be combined or interchanged either in whole or in part. In the foregoing descriptions of the various embodiments, those embodiments which refer to another embodiment may be appropriately combined with other embodiments as will be appreciated by one of skill in the art. Furthermore, those of ordinary skill in the art will appreciate that the foregoing description is by way of example only, and is not intended to limit the invention.

Claims

1. A process for producing acesulfame potassium, the process comprising the steps of:

(a) reacting a first reaction mixture comprising: sulfamic acid, an amine, and from 1 wppm to 1 wt % wppm acetic acid
to form an amidosulfamic acid salt;
(b) reacting the amidosulfamic acid salt with diketene to form an acetoacetamide salt;
(c) deriving the acesulfame potassium from the acetoacetamide salt,
wherein a molar ratio of acetic acid to sulfamic acid in the first reaction mixture is less than 0.095:1.

2. The process of claim 1, wherein step (c) comprises:

reacting the acetoacetamide salt with a cyclizing agent to form a cyclic sulfur trioxide adduct;and
deriving the acesulfame potassium composition from the cyclic sulfur trioxide adduct.

3. The process of claim 2, wherein the deriving comprises:

hydrolyzing the cyclic sulfur trioxide adduct to form acesulfame-H; and
neutralizing the acesulfame-H with potassium hydroxide to form the potassium acesulfame.

4. The process of claim 1, wherein the amine comprises triethylamine.

5. The process of claim 1, wherein the reaction in step (a) is conducted at an amine excess of less than 6 mol %.

6. The process of claim 1, wherein the amidosulfamic acid salt has a yellowing index less than 5 and/or the acetoacetamide salt has a yellowing index less than 45.

7. The process of claim 1, wherein a molar ratio of amine to sulfamic acid in the first reaction mixture is less than 1.06:1.

8. The process of claim 1, wherein the process does not comprise an acetic acid removal step.

9. The process of claim 1, wherein step (b) comprises:

contacting the amidosulfamic acid salt and diketene to form a second reaction mixture; and
reacting the second reaction mixture to form the acetoacetamide salt.

10. A process for producing acesulfame potassium, the process comprising the steps of:

(a) reacting a first reaction mixture comprising: sulfamic acid, an amine, and from 1 wppm to 1 wt % wppm acetic acid
to form an amidosulfamic acid salt;
(b) reacting the amidosulfamic acid salt with diketene to form an acetoacetamide salt;
(c) deriving the acesulfame potassium from the acetoacetamide salt,
wherein the acesulfame potassium has a yellowing index less than 5.

11. A process for producing acesulfame potassium, the process comprising the steps of:

(a) reacting a first reaction mixture comprising: sulfamic acid, an amine, and from 1 wppm to 1 wt % wppm acetic acid
to form an amidosulfamic acid salt;
(b) reacting the amidosulfamic acid salt with diketene to form an acetoacetamide salt;
(c) deriving the acesulfame potassium from the acetoacetamide salt,
wherein a molar ratio of amine to sulfamic acid in the first reaction mixture is less than 1.06:1.

12. The process of claim 1, wherein the acetoacetamide salt has a yellowing index less than 25.

13. The process of claim 6, wherein the acetoacetamide salt has a yellowing index less than 25.

14. The process of claim 10, wherein the pH of the first reaction mixture is maintained at a level ranging from 5.5 to 7.0.

15. The process of claim 10, wherein the pH of the first reaction mixture is maintained at a level ranging from 6.1 to 6.4.

16. The process of claim 13, wherein the pH of the first reaction mixture is maintained at a level ranging from 6.1 to 6.4.

17. The process of claim 10, wherein the pH of the first reaction mixture is maintained at a level greater than 5.5.

18. The process of claim 10, wherein the pH of the first reaction mixture is maintained at a level greater than 6.1.

19. The process of claim 10, wherein the pH of the first reaction mixture is maintained at a level less than 6.8.

20. The process of claim 10, wherein the pH of the first reaction mixture is maintained at a level less than 6.4.

21. The process of claim 10, wherein the first reaction mixture comprises acetic acid in an amount from 10 to 900 wppm, based on the total weight of the sulfamic acid, amine, and acetic acid.

22. The process of claim 10, wherein the first reaction mixture comprises acetic acid in an amount from 10 to 900 wppm, based on the total weight of the sulfamic acid, amine, and acetic acid.

23. The process of claim 10, wherein the first reaction mixture comprises acetic acid in an amount less than 100 wppm, based on the total weight of the sulfamic acid, amine, and acetic acid.

24. The process of claim 10, wherein the first reaction mixture further comprises solvent and wherein the first reaction mixture comprises acetic acid in an amount less than 0.175 wt %, based on the total weight of the sulfamic acid, amine, acetic acid, and solvent.

25. The process of claim 20, wherein the first reaction mixture further comprises solvent and wherein the first reaction mixture comprises acetic acid in an amount less than 0.175 wt %, based on the total weight of the sulfamic acid, amine, acetic acid, and solvent.

26. The process of claim 10, wherein the first reaction mixture comprises at least 35 wt % amine, based on the total weight of the sulfamic acid, amine, and acetic acid.

27. The process of claim 10, wherein the first reaction mixture comprises from 1 wppm to 900 wppm acetic acid and from 35 wt % to 75 wt % amine, based on the total weight of the sulfamic acid, amine, and acetic acid.

28. The process of claim 10, wherein the first reaction mixture comprises from 45 wt % to 85 wt % solvent, based on the total weight of the sulfamic acid, amine, acetic acid, and solvent.

29. The process of claim 10, wherein the molar ratio of acetic acid to sulfamic acid in the first reaction mixture ranges from 0.001:1 to 0.06:1.

30. The process of claim 10, wherein the molar ratio of amine to sulfamic acid in the first reaction mixture is greater than 1:1.

31. The process of claim 29, wherein the molar ratio of amine to sulfamic acid in the first reaction mixture is greater than 1:1.

32. The process of claim 10, wherein the amidosulfamic acid salt, as formed, has a yellowing index less than 5.

33. The process of claim 10, wherein the amidosulfamic acid salt, as formed, has a yellowing index less than 2.

34. The process of claim 29, wherein the amidosulfamic acid salt, as formed, has a yellowing index less than 2.

35. The process of claim 10, wherein the amidosulfamic acid salt, as formed, has a yellowing index less than 0.5.

36. The process of claim 10, wherein the acetoacetamide salt, as formed, has a yellowing index less than 25.

37. The process of claim 10, wherein the acetoacetamide salt, as formed, has a yellowing index less than 10.

38. The process of claim 10 wherein the acesulfame potassium has a yellowing index less than 3.

39. The process of claim 32, wherein the acesulfame potassium has a yellowing index less than 0.5.

40. The process of claim 10, wherein the pH of the first reaction mixture is maintained at a level ranging from 5.9 to 6.8, and wherein the amidosulfamic acid salt, as formed, has a yellowing index less than 5.

41. The process of claim 10, wherein the pH of the first reaction mixture is maintained at a level ranging from 6.1 to 6.4, wherein the amidosulfamic acid salt, as formed, has a yellowing index less than 5, and wherein the acetoacetamide salt, as formed, has a yellowing index less than 25.

42. The process of claim 10, wherein the pH of the first reaction mixture is maintained at a level ranging from 6.1 to 6.4, wherein the amidosulfamic acid salt, as formed, has a yellowing index less than 2, wherein the acetoacetamide salt, as formed, has a yellowing index less than 10, and wherein the acesulfame potassium has a yellowing index less than 3.

43. The process of claim 10, wherein the acetoacetamide salt, as formed, has a yellowing index and wherein the yellowing index of the acetoacetamide salt is less than the yellowing index of the acesulfame potassium.

44. The process of claim 20, wherein the first reaction is conducted at a temperature greater than 25° C.

45. The process of claim 10, wherein first reaction and the acetoacetamide salt formation reaction are conducted in the same reactor.

46. The process of claim 10, wherein first reaction and the acetoacetamide salt formation reaction are conducted in different reactors.

47. The process of claim 10, wherein the pH of the acetoacetamide salt formation reaction ranges from 5.9 to 6.8.

48. The process of claim 10, wherein the pH of the first reaction mixture ranges from 5.9 to 6.8 and the pH of the acetoacetamide salt formation reaction ranges from 5.9 to 6.8.

49. The process of claim 10, wherein the first reaction and the acetoacetamide salt formation reaction are conducted in separate reactors and wherein some of the amine from the first reaction is carried through to the reaction mixture of the acetoacetamide salt formation reaction.

50. The process of claim 49, wherein the acetoacetamide salt formation reaction mixture comprises the amidosulfamic acid salt, and carried-through amine.

51. The process of claim 10, wherein the pH of the acetoacetamide salt formation reaction is maintained at a level ranging from 5.5 to 7.0, wherein the acetoacetamide salt, as formed, has a yellowing index less than 10, and wherein the acesulfame potassium has a yellowing index less than 3.

52. The process of claim 10, wherein the pH of the acetoacetamide salt formation reaction is maintained at a level ranging from 6.1 to 6.4, wherein the acetoacetamide salt, as formed, has a yellowing index less than 10, and wherein the acesulfame potassium has a yellowing index less than 3.

53. The process of claim 10, wherein the first reaction is conducted at an amine excess of less than 6 mol %.

54. The process of claim 10, wherein the first reaction is conducted at an amine excess of less than 3 mol %.

55. The process of claim 10, further comprising: maintaining the pH of the first reaction by controlling the content of acetic acid and amine, and wherein the controlling comprises maintaining the concentration of acetic acid between 1 wppm and 1 wt % and the concentration of amine between 35 wt % and 75 wt %.

56. The process of claim 10, wherein the acetoacetamide salt formation reaction comprises less than 0.157 wt % acetic acid, from 3 wt % to 45 wt % amidosulfamic acid salt, from 1 wt % to 30 wt % diketene, and from 45 wt % to 85 wt % solvent.

57. The process of claim 10, wherein step (c) comprises:

reacting the acetoacetamide salt with a cyclizing agent to form a cyclic sulfur trioxide adduct; and
deriving the acesulfame potassium composition from the cyclic sulfur trioxide adduct.

58. The process of claim 57, wherein the deriving comprises:

hydrolyzing the cyclic sulfur trioxide adduct to form acesulfame-H; and
neutralizing the acesulfame-H with potassium hydroxide to form the acesulfame potassium.

59. The process of claim 10, wherein the amine comprises triethylamine.

60. The process of claim 57, wherein the acetoacetamide salt formation reaction mixture comprises diketene in an amount from 1 wt % to 30 wt %, based on total weight of the acetoacetamide salt formation reaction mixture including solvent.

61. The process of claim 53, wherein the acetoacetamide salt formation reaction mixture comprises from 3 wt % to 45 wt % of the amidosulfamic acid salt, from 1 wt % to 30 wt % of the diketene, and from 45 wt % to 85 wt % solvent based on total weight of the acetoacetamide salt formation reaction mixture.

62. The process of claim 54, wherein the diketene is present in excess to the amount of the amidosulfamic acid salt.

63. The process of claim 62, wherein the excess is less than 10 mol %.

64. The process of claim 62, wherein the reacting of the first reaction mixture is conducted at a temperature from 0° C. to 25° C.

65. The process of claim 10, wherein the pH of the first reaction mixture is maintained at a level ranging from 5.5 to 7.0, and wherein the acetoacetamide salt formation reaction is conducted in the presence of less than 0.157 wt % acetic acid, based on the total weight of the acetoacetamide salt formation reaction, and wherein the process produces at least 50 grams of acesulfame potassium per hour.

66. The process of claim 64, wherein the pH of the first reaction mixture is maintained at 5.9 to 6.8, wherein the amidosulfamic acid salt, as formed, has a yellowing index less than 5, and wherein the acetoacetamide salt, as formed, has a yellowing index less than 25.

67. The process of claim 64, wherein the pH of the first reaction mixture is maintained at a level ranging from 6.1 to 6.4, wherein the amidosulfamic acid salt, as formed, has a yellowing index less than 2, wherein the acetoacetamide salt, as formed, has a yellowing index less than 10, and wherein the acesulfame potassium has a yellowing index less than 3.

68. The process of claim 65, wherein the pH of the first reaction mixture is substantially similar to the pH of the acetoacetamide salt formation reaction mixture.

69. The process of claim 65, wherein the acetoacetamide salt, as formed, has a yellowing index less than 25, and the acesulfame potassium has a yellowing index less than 3.

70. The process of claim 64, wherein the pH of the first reaction mixture is maintained at a level ranging from 5.9 to 6.8, wherein the amidosulfamic acid salt, as formed, has a yellowing index less than 5, and wherein the acetoacetamide salt, as formed, has a yellowing index less than 25.

71. The process of claim 10, wherein the process produces at least 50 grams of acesulfame-K per hour, and wherein the first reaction is conducted at a temperature greater than 10° C.

72. The process of claim 20, wherein the process produces at least 50 grams of acesulfame-K per hour, and wherein the first reaction is conducted at a temperature greater than 10° C.

73. The process of claim 10, wherein the acetoacetamide salt formation reaction is conducted in the presence of less than 0.157 wt % acetic acid, and wherein the first reaction mixture comprises from 1 wppm to 900 wppm acetic acid, based on a total weight of the sulfamic acid, the amine, and the acetic acid.

74. The process of claim 20, wherein the acetoacetamide salt formation reaction is conducted in the presence of less than 0.157 wt % acetic acid, and wherein the first reaction mixture comprises from 1 wppm to 900 wppm acetic acid, based on a total weight of the sulfamic acid, the amine, and the acetic acid.

75. The process of claim 10, wherein the acetoacetamide salt formation reaction is conducted in the presence of less than 0.157 wt % acetic acid, and wherein the first reaction mixture comprises from 100 wppm to 1 wt % acetic acid, based on a total weight of the sulfamic acid, the amine, and the acetic acid.

76. The process of claim 62, wherein the first reaction mixture further comprises solvent and wherein the first reaction mixture comprises the acetic acid present in an amount from 1 wppm to 150 wppm acetic acid, based on a total weight of the sulfamic acid, the amine, the acetic acid, and the solvent.

77. The process of claim 76, wherein the molar ratio of the acetic acid to the sulfamic acid in the first reaction mixture is less than 0.095:1.

78. The process of claim 76, wherein the amidosulfamic acid salt formation reaction mixture comprises from 3 wt % to 45 wt % amidosulfamic acid salt, from 1 wt % to 30 wt % diketene, and from 45 wt % to 85 wt % solvent, based on a total weight of the amidosulfamic acid salt formation reaction mixture.

79. The process of claim 10, further comprising the step of:

maintaining the pH of the first reaction by controlling the content of acetic acid and amine in the first reaction mixture;
wherein the maintaining is achieved by maintaining a molar ratio of acetic acid to sulfamic acid at less than 0.095:1.

80. The process of claim 79, wherein the pH of the first reaction mixture is maintained at 5.5 to 7.0.

81. The process of claim 79, wherein the controlling comprises maintaining the concentration of acetic acid between 1 wppm and 1 wt % and the concentration of amine between 35 wt % and 75 wt %.

82. The process of claim 10, wherein the reacting the amidosulfamic acid salt with diketene to form an acetoacetamide salt step is carried out in a second reaction mixture comprising less than 0.157 wt % acetic acid, from 3 wt % to 45 wt % amidosulfamic acid salt, from 1 wt % to 30 wt % diketene, and from 45 wt % to 85 wt % solvent, based on a total weight of the amidosulfamic acid salt formation reaction mixture.

83. The process of claim 82, wherein first reaction and the acetoacetamide salt formation reaction are conducted in the same reactor.

84. The process of claim 83, wherein the pH of the first reaction mixture is maintained at a level ranging from 5.9 to 6.8 and the pH of the second reaction mixture is maintained at a level ranging from 5.9 to 6.8.

85. A process for producing acesulfame potassium, the process comprising the steps of:

(a) reacting a first reaction mixture comprising: sulfamic acid, triethylamine, and from 1 wppm to 1 wt % acetic acid, at a molar ratio of acetic acid to sulfamic acid less than 0.095:1, at a molar ratio of amine to sulfamic acid less than 1.06:1, at an amine excess less than 6 mol %, to form a trialkyl ammonium amidosulfamic acid salt having a yellowing index less than 5;
(b) contacting the amidosulfamic acid salt and diketene to form a second reaction mixture and reacting the second reaction mixture at a pH from 5.5 to 7.0 to form an acetoacetamide salt having a yellowing index less than 45;
(c) reacting the acetoacetamide salt with a cyclizing agent to form a cyclic sulfur trioxide adduct; and
(d) hydrolyzing the cyclic sulfur trioxide adduct to form acesulfame-H; and
(e) neutralizing the acesulfame-H with potassium hydroxide to form the potassium acesulfame;
wherein the acesulfame potassium has a yellowing index less than 5.

86. A process for producing acesulfame potassium, the process comprising the steps of:

(a) reacting a first reaction mixture comprising: sulfamic acid, triethylamine, and from 1 wppm to 1 wt % acetic acid to form a trialkyl ammonium amidosulfamic acid salt having a yellowness index less than 5;
(b) contacting the amidosulfamic acid salt with diketene to form a second reaction mixture and reacting the second reaction mixture to form an acetoacetamide salt;
(c) deriving the acesulfame potassium from the acetoacetamide salt.

87. The process of claim 86, wherein the reaction of the first reaction mixture is conducted at an amine excess of less than 6 mol %.

88. The process of claim 87, wherein the acetoacetamide salt formation reaction is conducted in the presence of less than 0.157 wt % acetic acid, and wherein the first reaction mixture comprises from 1 wppm to 900 wppm acetic acid, based on a total weight of the sulfamic acid, the amine, and the acetic acid.

89. The process of claim 87, wherein the pH of the first reaction mixture is maintained at less than 6.8.

90. The process of claim 87, wherein the acesulfame potassium has a yellowing index less than 3.

91. The process of claim 88, wherein the acesulfame potassium has a yellowing index less than 3.

92. A process for producing acesulfame potassium, the process comprising the steps of:

(a) reacting a first reaction mixture comprising: sulfamic acid, triethylamine, and from 1 wppm to 1 wt % acetic acid to form a trialkyl ammonium amidosulfamic acid salt;
(b) contacting the amidosulfamic acid salt with diketene to form a second reaction mixture and reacting the second reaction mixture to form an acetoacetamide salt having a yellowing index less than 25;
(c) deriving the acesulfame potassium from the acetoacetamide salt.

93. The process of claim 92, wherein the reaction of the first reaction mixture is conducted at an amine excess of less than 6 mol %.

94. The process of claim 93, wherein the molar ratio of acetic acid to sulfamic acid in the first reaction mixture ranges from 0.001:1 to 0.06:1.

95. The process of claim 93, wherein the second reaction mixture further comprises ammonium acetate salt.

96. The process of claim 93, wherein the acesulfame potassium has a yellowing index less than 3.

97. The process of claim 95, wherein the acesulfame potassium has a yellowing index less than 3.

98. A process for producing acesulfame potassium, the process comprising the steps of:

(a) reacting a first reaction mixture comprising: sulfamic acid, triethylamine, and acetic acid at a pH from 5.9 to 6.8 to form a trialkyl ammonium amidosulfamic acid salt having a yellowing index less than 5;
(b) contacting the amidosulfamic acid salt with diketene to form a second reaction mixture and reacting the second reaction mixture to form an acetoacetamide salt;
(c) deriving the acesulfame potassium from the acetoacetamide salt.

99. The process of claim 98, wherein the acetoacetamide salt formation reaction is conducted in the presence of less than 0.157 wt % acetic acid, and wherein the first reaction mixture comprises from 1 wppm to 900 wppm acetic acid, based on a total weight of the sulfamic acid, the amine, and the acetic acid.

100. The process of claim 98, wherein the acesulfame potassium has a yellowing index less than 3.

101. The process of claim 99, wherein the acesulfame potassium has a yellowing index less than 3.

102. The process of claim 98, wherein the second reaction mixture further comprises ammonium acetate salt.

103. The process of claim 99, wherein the second reaction mixture further comprises ammonium acetate salt.

104. The process of claim 100, wherein first reaction mixture is reacted at a pH from 6.1 to 6.4.

105. A process for producing acesulfame potassium, the process comprising the steps of:

(a) reacting a first reaction mixture comprising: sulfamic acid, triethylamine, and acetic acid at a pH from 5.9 to 6.8 to form a trialkyl ammonium amidosulfamic acid salt;
(b) contacting the amidosulfamic acid salt with diketene to form a second reaction mixture and reacting the second reaction mixture to form an acetoacetamide salt having a yellowing index less than 25;
(c) deriving the acesulfame potassium from the acetoacetamide salt.

106. The process of claim 105, wherein the molar ratio of acetic acid to sulfamic acid in the first reaction mixture ranges from 0.001:1 to 0.06:1.

107. The process of claim 106, wherein the reaction of the first reaction mixture is conducted at an amine excess of less than 6 mol %.

108. The process of claim 105, wherein the acetoacetamide salt formation reaction is conducted in the presence of less than 0.157 wt % acetic acid.

109. The process of claim 106, wherein the acetoacetamide salt formation reaction is conducted in the presence of less than 0.157 wt % acetic acid.

110. The process of claim 106, wherein the acesulfame potassium has a yellowing index less than 3.

111. The process of claim 108, wherein the acesulfame potassium has a yellowing index less than 3.

112. The process of claim 110, wherein first reaction mixture is reacted at a pH from 6.1 to 6.4.

113. A process for producing acesulfame potassium, the process comprising the steps of:

(a) reacting a first reaction mixture comprising: sulfamic acid, an amine in a molar excess of 5 mol. % or less, and from 0.9 wt. % to 1 wt. % acetic acid to form an amidosulfamic acid salt, wherein the first reaction mixture is maintained at a pH of from 6.1 to 6.4;
(b) reacting the amidosulfamic acid salt with diketene to form an acetoacetamide salt;
(c) deriving the acesulfame potassium from the acetoacetamide salt,
wherein a molar ratio of amine to sulfamic acid in the first reaction mixture is from 1:1 to 1.05:1.

114. The process of claim 113, wherein step (c) comprises:

reacting the acetoacetamide salt with a cyclizing agent to form a cyclic sulfur trioxide adduct; and
deriving the acesulfame potassium composition from the cyclic sulfur trioxide adduct.

115. The process of claim 114, wherein the deriving comprises:

hydrolyzing the cyclic sulfur trioxide adduct to form acesulfame-H; and
neutralizing the acesulfame-H with potassium hydroxide to form the potassium acesulfame.

116. The process of claim 113, wherein the amine comprises triethylamine.

117. The process of claim 113, wherein the amidosulfamic acid salt has a yellowing index less than 5.

118. The process of claim 113, wherein the acetoacetamide salt has a yellowing index less than 25.

119. The process of claim 113, wherein the first reaction mixture comprises from 45 wt % to 85 wt % solvent, based on the total weight of the sulfamic acid, amine, acetic acid, and solvent.

120. The process of claim 113, wherein the molar ratio of amine to sulfamic acid in the first reaction mixture is greater than 1:1.

121. The process of claim 113, wherein the diketene is present in excess to the amount of the amidosulfamic acid salt.

122. The process of claim 113, wherein the diketene is present in excess in an amount of less than 10 mol. % to the amount of the amidosulfamic acid salt.

123. The process of claim 113, wherein the process produces at least 50 grams of acesulfame-K per hour, and wherein the first reaction is conducted at a temperature greater than 10° C.

124. A process for producing acesulfame potassium, the process comprising the steps of:

(a) reacting a first reaction mixture comprising: sulfamic acid, an amine, and from 1 wppm to 1 wt. % acetic acid to form an amidosulfamic acid salt;
(b) reacting the amidosulfamic acid salt with diketene to form an acetoacetamide salt;
(c) deriving the acesulfame potassium from the acetoacetamide salt,
wherein a molar ratio of amine to sulfamic acid in the first reaction mixture is from 1:1 to 1.05:1.

125. The process of claim 124, wherein the acetic acid is present in an amount of from 0.9 wt. % to 1 wt. %.

126. The process of claim 124, wherein the first reaction mixture is maintained at a pH of from 6.1 to 6.4.

127. The process of claim 124, wherein step (c) comprises:

reacting the acetoacetamide salt with a cyclizing agent to form a cyclic sulfur trioxide adduct; and
deriving the acesulfame potassium composition from the cyclic sulfur trioxide adduct.

128. The process of claim 127, wherein the deriving comprises:

hydrolyzing the cyclic sulfur trioxide adduct to form acesulfame-H; and
neutralizing the acesulfame-H with potassium hydroxide to form the potassium acesulfame.

129. The process of claim 124, wherein the amine comprises triethylamine.

130. The process of claim 124, wherein the amidosulfamic acid salt has a yellowing index less than 5.

131. The process of claim 124, wherein the acetoacetamide salt has a yellowing index less than 25.

132. The process of claim 124, wherein the first reaction mixture comprises from 45 wt % to 85 wt % solvent, based on the total weight of the sulfamic acid, amine, acetic acid, and solvent.

133. The process of claim 124, wherein the molar ratio of amine to sulfamic acid in the first reaction mixture is greater than 1:1.

134. The process of claim 124, wherein the diketene is present in excess in an amount of less than 10 mol. % to the amount of the amidosulfamic acid salt.

135. The process of claim 134, wherein the excess of the diketene is less than 10 mol %.

136. The process of claim 124, wherein the process produces at least 50 grams of acesulfame-K per hour, and wherein the first reaction is conducted at a temperature greater than 10° C.

Referenced Cited
U.S. Patent Documents
2522512 September 1950 Harman et al.
3759955 September 1973 Jacobs et al.
4607100 August 19, 1986 Clauss
4638063 January 20, 1987 Clauss et al.
4695629 September 22, 1987 Clauss et al.
4804755 February 14, 1989 Reschling et al.
4806639 February 21, 1989 Reuschling et al.
4876341 October 24, 1989 Schutz et al.
5011982 April 30, 1991 Clauss et al.
5084180 January 28, 1992 Boateng
5103046 April 7, 1992 Clauss et al.
5185090 February 9, 1993 Ryer et al.
5242612 September 7, 1993 Ryer et al.
5314633 May 24, 1994 Ryer et al.
5326487 July 5, 1994 Ryer et al.
5334397 August 2, 1994 Ream et al.
5534170 July 9, 1996 Watts
5700420 December 23, 1997 Nakagawa et al.
5744010 April 28, 1998 Roscher et al.
5808159 September 15, 1998 Giebeler
7373791 May 20, 2008 Leehr
7408059 August 5, 2008 Kobayashi et al.
7977514 July 12, 2011 Peters et al.
8182756 May 22, 2012 Liu et al.
20030065172 April 3, 2003 Tian et al.
20030065218 April 3, 2003 Mollenkopf
20080076919 March 27, 2008 Liu et al.
20090318685 December 24, 2009 Saito
20090318686 December 24, 2009 Saito et al.
20100274057 October 28, 2010 Peters et al.
20110256045 October 20, 2011 Brietzke et al.
20110256046 October 20, 2011 Brietzke et al.
Foreign Patent Documents
123923 September 2009 CA
85104277 June 1985 CN
86105339 April 1987 CN
1883790 December 2006 CN
1883790 December 2006 CN
1884063 December 2006 CN
200949088 September 2007 CN
101124981 February 2008 CN
101148300 March 2008 CN
101157666 April 2008 CN
101787001 July 2010 CN
101913898 December 2010 CN
201921689 August 2011 CN
102225333 October 2011 CN
102359926 February 2012 CN
102380226 March 2012 CN
102866042 January 2013 CN
103018368 April 2013 CN
103130743 June 2013 CN
103570592 February 2014 CN
103588728 February 2014 CN
103613566 March 2014 CN
103960558 August 2014 CN
104193625 December 2014 CN
104209052 December 2014 CN
104225956 December 2014 CN
104292181 January 2015 CN
204320227 May 2015 CN
105152446 December 2015 CN
105198778 December 2015 CN
106262665 January 2017 CN
106267879 January 2017 CN
106349009 January 2017 CN
106349300 January 2017 CN
206001191 March 2017 CN
206001201 March 2017 CN
206001439 March 2017 CN
106625198 May 2017 CN
107406806 November 2017 CN
1249262 October 1966 DE
1268141 May 1968 DE
2453063 May 1976 DE
3522470 January 1987 DE
3522470 January 1987 DE
3531357 March 1987 DE
3545196 June 1987 DE
3545196 June 1987 DE
0155634 March 1985 EP
0215347 March 1987 EP
54032406 March 1979 JP
9319055 March 1993 WO
2011133468 October 2011 WO
Other references
  • Order No. 7: Initial Determination Granting Complainant's Motion for Termination of the Investigation Based on Withdrawal of the Complaint for Inv. No. 337-TA-1030, dated Mar. 1, 2017.
  • Notice of Commission Determination Not to Review an Initial Determination Granting Respondent Vitasweet's Motion to De-Designate Improperly-Designated Confidential Business Information, filed in the U.S. International Trade Commission for Inv. No. 337-TA-1030, issued May 11, 2017.
  • Notice of Commission Determination Not to Review an Initial Determination Granting Complainants' Motion for Termination of the Investigation Based on Withdrawal of the Complaint; Termination of the Investigation, filed in the U.S. International Trade Commission for Inv. No. 337-TA-1030, issued Mar. 20, 2017.
  • Initial Determination Granting Respondent Vitasweet Co., Ltd.'s Motion to De-Designate Improperly Designated Confidential Business Information for Inv. No. 337-TA-1030, dated Mar. 28, 2017.
  • International Trade Commission [Investigation No. 337-TA-1030] published in the Federal Register, Notices, vol. 82, No. 56, dated Mar. 24, 2017.
  • Vitasweet—Notice of Opposition to European Patent Application No. EP 2861569, dated Nov. 8, 2017.
  • Suzhou—Notice of Opposition to European Patent Application No. EP 2861569, dated Nov. 8, 2017.
  • Anhui—Notice of Opposition to European Patent Application No. EP 2861569, dated Nov. 8, 2017.
  • “Non-Final Office Action” dated Jul. 25, 2014, issued in U.S. Appl. No. 13/901,735.
  • “Final Office Action” dated Nov. 6, 2014, issued in U.S. Appl. No. 13/901,735.
  • “Notice of Allowance” dated Jan. 29, 2015, issued in U.S. Appl. No. 13/901,735.
  • “First Office Action”, dated Nov. 18, 2015, issued in CN201380029410.2.
  • “Second Office Action”, dated Jun. 7, 2016, issued in CN201380029410.2.
  • First Requests for Production of Documents and Things From Anhui Jinhe Industrial Co., Ltd. to Celanese International Corporation, Celanese Sales U.S. Ltd., and Celanese IP Hungary BT (Nos. 1-24) dated Dec. 1, 2016.
  • First Set of Interrogatories From Anhui Jinhe Industrial Co., Ltd. to Celanese International Corporation, Celanese Sales U.S. Ltd., and Celanese IP Hungary BT (Nos. 1-4) Dated Dec. 16, 2016.
  • First Requests for Production of Documents and Things From Suzhou Hope Technology Co., Ltd. to Celanese International Corporation, Celanese Sales U.S. Ltd., and Celanese IP Hungary BT (Nos. 1-24) Dated Dec. 12, 2016.
  • First Set of Interrogatories From Suzhou Hope Technology Co., Ltd. to Celanese International Corporation, Celanese Sales U.S. Ltd., and Celanese IP Hungary BT (Nos. 1-4) Dated Dec. 12, 2016.
  • Second Requests for Production of Documents and Things From Anhui Jinhe Industrial Co., Ltd. and Suzhou Hope Technology Co., Ltd. to Celanese International Corporation, Celanese Sales U.S. Ltd., and Celanese IP Hungary BT (Nos. 25-119) dated Dec. 13, 2016.
  • Second Set of Interrogatories From Anhui Jinhe Industrial Co., Ltd. and Suzhou Hope Technology Co., Ltd. to Celanese International Corporation, Celanese Sales U.S. Ltd., and Celanese IP Hungary BT (Nos. 5-53) dated Dec. 13, 2016.
  • Respondent Suzhou Hope Technology Co., Ltd.'s Response to Celanese Complainants' Notice of Inspection dated Dec. 14, 2016.
  • Response of Suzhou Hope Technology Co., Ltd. to Complaint of Celanese International Corporation, Celanese Sales U.S. Ltd., and Celanese IP Hungary BT and Notice of Investigation Under Section 337 dated Dec. 19, 2016.
  • Response of Anhui Jinhe Industrial Co., Ltd. to Complaint of Celanese International Corporation, Celanese Sales U.S. Ltd., and Celanese IP Hungary BT and Notice of Investigation Under Section 337 dated Dec. 19, 2016.
  • Respondent Anhui Jinhe Industrial Co., Ltd.'s Response to Celanese Complainants' Notice of Inspection dated Dec. 14, 2016.
  • Celanese Complainants' First Set of Interrogatories to Respondent Anhui Jinhe Industrial Co., Ltd. dated Nov. 29, 2016.
  • Celanese Complainants' First Set of Interrogatories to Respondent Suzhou Hope Technology Co., Ltd. dated Nov. 29, 2016.
  • Celanese Complainants' First Set of Interrogatories to Respondent Vitasweet Co., Ltd. Dated Nov. 29, 2016.
  • Celanese Complainants' First Set of Requests for Production of Documents and Things to Respondent Anhui Jinhe Industrial Co., Ltd. Dated Nov. 29, 2016.
  • Celanese Complainants' First Set of Requests for Production of Documents and Things to Respondent Suzhou Hope Technology Co., Ltd. dated Nov. 29, 2016.
  • Celanese Complainants' First Set of Requests for Production of Documents and Things to Respondent Vitasweet Co., Ltd. dated Nov. 29, 2016.
  • Celanese Complainants' Notice of Inspection to Respondent Anhui Jinhe Industrial Co., Ltd. dated Nov. 29, 2016.
  • Celanese Complainants' Notice of Inspection to Respondent Suzhou Hope Technology Co., Ltd. dated Nov. 29, 2016.
  • Celanese Complainants' Notice of Inspection to Respondent Vitasweet Co., Ltd. dated Nov. 29, 2016.
  • Respondent Vitasweet Co., Ltd.'s First Request for Production of Documents and Things to Complainants Celanese International Corporation, Celanese Sales U.S. Ltd., and Celanese IP Hungary BT (Nos. 1-35) dated Dec. 16, 2016.
  • Respondent Vitasweet Co., Ltd.'S First Set of Interrogatories to Complainants Celanese International Corporation, Celanese Sales U.S. Ltd., and Celanese IP Hungary BT (Nos. 1-32) dated Dec. 16, 2016.
  • Respondent Vitasweet Co., Ltd.'s Notice of Inspection to Complainants Celanese International Corporation, Celanese Sales U.S. Ltd., and Celanese IP Hungary BT dated Dec. 16, 2016.
  • Respondent Vitasweet Co., Ltd's Responses to Celanese Complainants' First Set of Requests for Production of Documents and Things dated Dec. 16, 2016.
  • Respondent Vitasweet Co., Ltd.'s Second Set of Interrogatories to Complainants Celanese International Corporation, Celanese Sales U.S. Ltd., and Celanese IP Hungary BT (Nos. 33-47) dated Dec. 20, 2016.
  • Respondent Vitasweet Co., Ltd.'s Second Request for Production of Documents and Things to Complainants Celanese International Corporation, Celanese Sales U.S. Ltd., and Celanese IP Hungary BT (Nos. 36-80) Dated Dec. 20, 2016.
  • Respondent Vitasweet Co., Ltd.'s Third Request for Production of Documents and Things to Complainants Celanese International Corporation, Celanese Sales U.S. Ltd., and Celanese IP Hungary BT (Nos. 81-87) Dated Jan. 10, 2017.
  • Respondent Vitasweet Co., Ltd.'s Third Set of Interrogatories to Complainants Celanese International Corporation, Celanese Sales U.S. Ltd., and Celanese IP Hungary BT (Nos. 48-53) Dated Jan. 10, 2017.
  • Respondent Vitasweet Co., Ltd's Response to Celanese Complainants' Notice of Inspection dated Dec. 16, 2016.
  • Letter to Secretary Barton Regarding Certain High-Potency Sweeteners, Processes for Making Same, and Products Containing Same, 337-TA-1030—Public Version of Confidential Exhibit 1 to Vitasweet's Response to Complaint and Notice of Investigation Dated Dec. 19, 2016.
  • Respondent Vitasweet Co., Ltd.'s Response to the Complaint and Notice of Investigation dated Dec. 19, 2016.
  • Communication Pursuant to Article 94(3) EPC Issued European Patent Application No. 13 727 188.8 dated Feb. 11, 2016.
  • Order No. 4: Denying Complainant Celanese's Motion to Stay in Inv. No. 337-TA-1030, dated Jan. 27, 2017.
  • Reply in Support of Complainant's Motion for Termination of the Investigation based on Withdrawal of the Complaint in Inv. No. 337-TA-1030, dated Feb. 17, 2017.
  • Memorandum of Anhui Jinhe Industrial Co., Ltd. and Suzhou Hope Technology Co., Ltd. In Opposition to Complainant Celanese's Motion to Terminate in Inv. No. 337-TA-1030, dated Feb. 13, 2017.
  • Xiangsheng, et al., “Synthesis of Acesulfame Potassium”, Fine Chemicals, vol. 13, 1996, pp. 1-15.
  • Sunnett Brochure, “Acesulfame Potassium”, Celanese, Apr. 2014.
  • ASTM E 313-05, “Standard Practice for Calculating Yellowness and Whiteness Indices from Instrumentally Measured Color Coordinates,” Oct. 1, 2005, 6 pages.
  • Duan et al., “Synthesis of Acesulfame Potassium,” Fine Chemicals, vol. 13, 1996, pp. 22-24.
  • Linkies et al., Synthesis, 1990, 5, 405-406.
  • Quality Information Pack—Sunett® from Nutrinova Nutrition Specialties & Food Ingredients, Quality Management & Regulatory Affairs, Feb. 2010, 20 pages.
  • Notice of Opposition, Nov. 8, 2017, 73 pages.
  • Reply of the Patent Proprietor to the Notice of Opposition, Aug. 24, 2018, 20 pages.
  • Summons to Attend Oral Proceedings, Nov. 28, 2018, 12 pages.
  • Written Submission by Opponent, May 24, 2019, 15 pages.
  • Written Submission by Patentee, May 24, 2019, 26 pages.
  • Written Submission in Preparation to Oral Proceedings, Jul. 24, 2019, 12 pages.
  • Information About the Results of Oral Proceedings, Jul. 26, 2019, 10 pages.
  • Grounds of the Decision, Sep. 16, 2019, 21 pages.
  • Minutes of the Oral Proceedings, Sep. 16, 2019, 9 pages.
  • Statement of Grounds of Appeal, Dec. 20, 2019, 69 pages.
  • English Translation of Exhibit E1—Experiment report of “Synthesis of Potassium Acetylsulfamate” by Anhui Jinhe Industrial Co., Ltd. May 2020.
  • Anhui Jinhe Industrial Co., Ltd.'s Request for Invalidation dated May 30, 2020, 21 pages.
  • Exhibit 5—Research on the synthesis of sweetener acesulfame K, Yang Junlin et al., Thesis Collection of Industry Annual Conference held by Sweetener Professional Committee under China Food Additives and Ingredients Association in 2009 Only Abstract in English.
  • Exhibit 6—Research on the synthesis of sweetener acesulfame K, Jiang Yu, Science and Technology Innovation Herald, 2008 Not in English.
  • Exhibit 7—Research on the synthesis of sweetener acesulfame K, Feng Rui et al., Journal of Sichuan Normal University (Natural Science Edition), vol. 20, No. 1, pp. 55-59, Mar. 1999 Not in English.
  • Exhibit 8—Research on the synthesis process of sweetener acesulfame K, Yan Fu'an et al., Food Industry Science and Technology. pp. 74-76, No. 5, 2003, May 2003 Not in English.
  • Exhibit 9—The method for preparing the 4th-generation of synthetic sweetener acesulfame K, Tan Dong, Guangxi Chemical Industry, vol. 21, No, 1, 1992, pp. 40-43, Jan. 1992 Not in English.
  • Exhibit 14—Discussion on Factory Process Design for Acesulfame, Huang Linfeng, Master's Degree Thesis of Nanchang University, China Excellent. Master's Thesis Full-text Database (Electronic Journal) Engineering Science and Technology Series I, May 31, 2012 Only Abstract in English.
  • Exhibit E1—Experiment report of “Synthesis of Potassium Acetylsulfamate” by Anhui Jinhe Industrial Co.. Ltd. Mar. 2020. Only Appendixes in.
  • Exhibit G1—Analytical Chemistry, Higher Education Press, edited by Wuhan University, 4thedition, pp. 2 to 3. 2000 Not in English.
  • Exhibit G2—Factory Analysis and Laboratory Manual, Chen Biyou et al., Chemical industry Press, 2nd edition, pp. 18-20, 2009. Not in English.
  • Exhibit G3—Analytical Chemistry and Experimental Technology. LV Jie, Xie Qingjuan, People's Military Medical Press, 1stedition, p. 3, May 2012 Not in English.
  • Exhibit G5—Catalytic Synthesis of Ethyl Acetate from Sulfamic Acid, Zhang Changhua, Journal of Binzhou Normal College, vol. 18, No. 4, pp. 27-29, Dec. 2002 Only Abstract in English.
  • Exhibit G6—National Standard GB25540-2010, National Standard of Food Safety, Food Additive, acesulfame potassium 2011, not in English.
  • Exhibit G8—National Standard GB/T 23964-2009, triethylamine for industrial use 2010, not in English.
  • Exhibit G9—Industry Standard HG/T 2527-2011, sulfamic acid for industrial use 2012, not in English.
  • Exhibit G10—National Standard GB/T 4117-2008, dichloromethane for industrial use 2008, not in English.
  • Exhibit G11—National Standard GB/T 1628-2008, glacial acetic acid for industrial use 2009, not in English.
  • Response to the Invalidation Request, 32 pages Undated.
  • Affidavit of Dr. Arvind Yadav dated Aug. 31, 2020, 7 pages.
  • English Translation of Exhibit 5—Research on the synthesis of sweetener acesulfame K, Yang Junlin et al., Thesis Collection of Industry Annual Conference held by Sweetener Professional Committee under China Food Additives and Ingredients Association in 2009.
  • English Translation of Exhibit 6—Research on the synthesis of sweetener acesulfame K, Jiang Yu, Science and Technology Innovation Herald, 2008.
  • English Translation of Exhibit 7—Research on the synthesis of sweetener acesulfame K, Feng Rui et al., Journal of Sichuan Normal University (Natural Science Edition), vol. 20, No. 1, pp. 55-59, Mar. 1999.
  • English Translation of Exhibit 8—Research on the synthesis process of sweetener acesulfame K, Yan Fu'an et al., Food Industry Science and Technology, pp. 74-76, No. 5, 2003. May 2003
  • English Translation of Exhibit 9—The method for preparing the 4th-generation of synthetic sweetener acesulfame K, Tan Dong, Guangxi Chemical Industry, vol. 21, No. 1, 1992, pp. 40-43, Jan. 1992.
  • English Translation of Exhibit 14—Discussion on Factory Process Design for Acesulfame, Huang Linfeng, Master's Degree Thesis of Nanchang University, China Excellent Master's Thesis Full-text Database (Electronic Journal) Engineering Science and Technology Series I, May 31, 2012.
  • Linkies et al. Synthesis (1990), (5), 405-6.
  • Suenaga, T., “Ethylene-amine salt recovery—by converting the hydrochloride into the sulphate, and reacting with ammonia in aq. Solvent to ppte. Ammonium sulphate”, WPI/Thompson, vol. 1979, No. 16, XP 002598345 (See JP54032406).
Patent History
Patent number: RE48464
Type: Grant
Filed: Feb 13, 2017
Date of Patent: Mar 16, 2021
Assignee: Celanese Sales Germany GmbH (Suzbach)
Inventors: Michael J. Bayer (Eschborn), Stephan Brietzke (Wiesbaden), Peter Groer (Babenhausen), Christoph Mollenkopf (Frankfurt AM Main)
Primary Examiner: Timothy J. Kugel
Application Number: 15/431,665
Classifications
Current U.S. Class: Six-membered Hetero Ring Consists Of Oxygen, Sulfur, Nitrogen And Carbon (e.g., Oxathiazines, Etc.) (544/2)
International Classification: C07D 291/06 (20060101); C07D 307/02 (20060101); A23L 27/30 (20160101); C07C 307/02 (20060101);